WO2020054300A1 - Method and apparatus for determining quantity of endocrine disruptor and like - Google Patents
Method and apparatus for determining quantity of endocrine disruptor and like Download PDFInfo
- Publication number
- WO2020054300A1 WO2020054300A1 PCT/JP2019/031837 JP2019031837W WO2020054300A1 WO 2020054300 A1 WO2020054300 A1 WO 2020054300A1 JP 2019031837 W JP2019031837 W JP 2019031837W WO 2020054300 A1 WO2020054300 A1 WO 2020054300A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- reaction
- antigen
- antibody
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Definitions
- the present invention relates to a method and an apparatus for quantifying an endocrine disrupter or the like.
- the endocrine disrupting substance is a substance in which a chemical substance such as a pesticide discharged into the environment such as soil, river, and ocean is metabolically toxic by microorganisms that live in the environment.
- endocrine disrupting substances and the like chemical substances such as pesticides in the environment and endocrine disrupting substances derived from the chemical substances.
- the present invention has been made in view of the above circumstances, and an object of the present invention is to provide a quantification method and the like which can be carried out at a site where an environmental sample such as an endocrine disruptor is collected.
- a first aspect of the present invention is a quantification method for quantifying a target component contained in a sample solution using an antigen-antibody reaction, wherein the enzyme-labeled antigen or enzyme-labeled antibody labeled with an enzyme is labeled with the enzyme-labeled enzyme.
- an antigen-antibody reaction step of causing an antigen-antibody reaction, and adding a monomer whose polymerization reaction is promoted by the enzyme to the reaction section A polymerization reaction step of performing a polymerization reaction to generate a polymer from the monomer, an absorbance measurement step of measuring the absorbance of the polymer generated in the polymerization reaction step, and from the absorbance obtained in the absorbance measurement step, the target A quantification step of quantifying the components.
- a second aspect of the present invention is the method for quantification according to the first aspect, wherein the monomer is aniline and the polymer is polyaniline.
- a third aspect of the present invention is the quantification method according to the first or second aspect, wherein in the antigen-antibody reaction step, the reaction part containing the antibody is labeled with an enzyme together with the enzyme-labeled antigen. Add the unsampled sample solution.
- a fourth aspect of the present invention is a quantification apparatus for quantifying a target component contained in a sample solution by utilizing an antigen-antibody reaction, wherein the reaction section serves as a reaction field of the antigen-antibody reaction, and holds the sample solution. And a second container for holding an enzyme-labeled solution containing an enzyme-labeled product which is labeled with an enzyme and which is an antigen or an antibody in the antigen-antibody reaction, and is promoted by the enzyme.
- a third container for holding a substrate solution for the polymerization reaction to be performed, a first flow path for guiding the sample solution in the first container to the reaction section, and a solution of the enzyme-labeled substance in the second container.
- a light detection unit that detects light a first light guide path that guides light emitted by the light source unit to a measurement unit that is a part of the fourth flow path, and light from the measurement unit to the light detection unit.
- a fifth aspect of the present invention is the quantitative device according to the fourth aspect, wherein the light-absorbing section is made of a pigment-containing silicone member containing a pigment that absorbs light.
- a sixth aspect of the present invention is the quantitative device according to the fourth or fifth aspect, wherein the first light guide, the second light guide, and the light absorbing unit are made of silicone resin having the same refractive index. Material.
- a seventh aspect of the present invention is the quantitative device according to any one of the fourth to sixth aspects, wherein the first flow path and the second flow path are joined upstream from the reaction unit. ing.
- An eighth aspect of the present invention is the quantitative device according to any one of the fourth to seventh aspects, wherein a fourth container for holding an antibody solution used for the antigen-antibody reaction, A fourth flow path for guiding the antibody solution to the reaction section, wherein the enzyme-labeled product is an enzyme-labeled antigen that is an enzyme-labeled antigen.
- the reaction catalyzed by the enzyme is a polymerization reaction, so that the reaction is less affected by light or heat as compared with a conventional ELISA using a fluorescent substrate or a chromogenic substrate, and it can be used outdoors. It is possible to provide a quantification method or the like suitable for measurement. In addition, since the reaction time of the polymerization reaction is short, it is possible to quantify endocrine disrupting substances and the like in a short time.
- the quantification can be performed in a short time because the aniline radical polymerization reaction having a short reaction time is used.
- aniline is more stable to light and heat than fluorescent substrates used in conventional ELISA, and thus the quantification method of the present invention is suitable for outdoor measurement.
- aniline is inexpensive, expensive fluorescent reagents such as conventional ELISA are not required.
- an ELISA competitive method quantification can be performed in a small number of steps, so that the work load of the measurer is reduced, and the time required for quantification is reduced, and the on-site analysis is reduced. It becomes possible to provide a suitable quantification method.
- an ELISA sandwich method after an antibody is adsorbed on a substrate, an antigen is added to cause a first antigen-antibody reaction, and a labeled antibody is further added thereto to cause a second antigen-antibody reaction.
- the competition method as shown in the Examples, the antigen-antibody reaction is performed only once.
- the fourth aspect of the present invention it is possible to provide a quantification device that can measure the absorbance at a site where an endocrine disrupting substance or the like is collected to quantify the endocrine disrupting substance or the like. Further, since the stray light is absorbed by the light absorbing portion, it is possible to accurately determine the amount.
- the stray light incident on the light absorbing portion is absorbed by the pigment. Therefore, it hardly returns to the transparent resin forming the first light guide path and the second light guide path. Further, no stray light leaks from the light absorbing portion to the outside. Therefore, complicated multiple reflection of stray light hardly occurs.
- the transparent resin forming the first light guide path and the second light guide path and the pigment-containing resin forming the light-absorbing portion are made of the same resin, so that both resins are formed. It becomes possible to suppress the reflection and scattering of light at the contacting interface.
- the seventh aspect of the present invention it is possible to mix the sample solution in the first container and the enzyme-labeled product solution in the second container, and then guide the mixture to the reaction section.
- the antigen to be quantified and the enzyme-labeled antigen can be made to react with the antibody competitively after the antibody is adsorbed on the substrate in the reaction section.
- FIG. 1 is a flowchart of a method for quantifying an endocrine disrupting substance and the like of the present invention.
- 1 is an example of the configuration of an apparatus for quantifying an endocrine disrupter or the like of the present invention. It is a figure which shows the absorbance spectrum of aniline and the absorption spectrum after superposition
- FIG. 1 shows a flow chart of the method for quantifying an endocrine disrupter or the like of the present invention.
- the object of quantification was 3-phenoxybenzoic acid (3-PBA), which is a kind of metabolite of a diphenyl ether herbicide.
- HRP horseradish peroxidase
- an anti-3-PBA antibody that specifically binds to 3-PBA is injected into a reaction cell (an example of a “reaction section” in the claims) and adsorbed on a substrate in the reaction cell (S1).
- BSA bovine serum albumin
- BSA is a blocking agent for suppressing nonspecific adsorption of the labeled antigen to be injected in the next step to the substrate.
- a 3-PBA solution to be quantified an example of a “sample solution” in the claims
- a labeled 3-PBA solution an example of an “enzyme-labeled substance” and an “enzyme-labeled antigen” in the claims
- the mixture is injected into the reaction cell (S3, an example of the “antigen-antibody reaction step” in the claims).
- the labeled 3-PBA solution is a solution containing labeled 3-PBA in which 3-PBA as an antigen is labeled in advance with HRP, and the concentration of labeled 3-PBA is known.
- the present quantification method utilizes the radical polymerization reaction of aniline, the time required for quantification can be significantly reduced as compared with the conventional ELISA.
- the time required for the enzyme reaction of the conventional ELISA is several minutes, whereas the time required for the polymerization reaction of the present quantitative method is several seconds.
- Aniline is suitable for on-site analysis because it is far more stable to light and heat than fluorescent substrates and chromogenic substrates used in conventional ELISA.
- aniline is less expensive than the substrate used in the conventional ELISA. That is, according to the present quantification method, on-site analysis of endocrine disrupting substances and the like can be performed quickly, safely and inexpensively.
- FIG. 2 shows a configuration example of a quantification apparatus 1 for performing the quantification method of the present invention.
- the quantitative device 1 enables analysis by a flow analysis method (for example, Flow Injection Analysis).
- the quantification device 1 includes an antigen container 3 for holding a 3-PBA solution to be quantified (an example of a “first container” in the claims) and a labeled antigen for holding a labeled 3-PBA solution.
- Container 5 an example of a “second container” in the claims
- an antibody container 7 for holding an antibody solution an example of a “fourth container” in the claims
- a blocking agent such as BSA
- a container 9 for blocking agent a container 11 for H 2 O 2 for holding a hydrogen peroxide solution (H 2 O 2 ), and a container 13 for an aniline for holding an aniline-containing solution.
- An example of a “third container”) a container 15 for a running buffer for holding a running buffer, a reaction cell 17 (an example of a “reaction unit” in claims) serving as a reaction field for an antigen-antibody reaction, Guide solution from each container to reaction cell 17
- An introduction channel 19 pumps P1-P7 for flowing the solution in the introduction channel 19, a three-way valve V1-V7 provided in the introduction channel 19 and capable of opening and closing, and introducing the solution from the reaction cell 17 to the outside.
- It has an optical measurement channel 21 (an example of a “fourth channel” in the claims) and an absorbance measurement unit 23 that measures the absorbance of polyaniline.
- the above-described opening / closing control of the three-way valve includes switching control of the flow direction of the fluid and On / Off control of the flow of the fluid.
- Each of the containers (the antigen container 3, the labeled antigen container 5, the antibody container 7, the blocking agent container 9, the H 2 O 2 container 11, the aniline container 13, and the running buffer container 15) (19 1, 19 2, 19 3, 19 4, 19 5, 19 6, 19 7) connected to a pump P1-P7 through the solution in each container by driving the pump P1-P7 is the introduction into channel 19 Flow enters reaction cell 17. Downstream of the pumps P1-P6, three-way valves V1-V6 that can be controlled to open and close are provided. The introduction flow path 19 10 between the merge point C3 and reaction cell 17 to be described later, the valve V7 is provided and the other is connected to the waste insertion 25. In FIG. 2, each valve is shown individually for easy understanding. However, a valve control mechanism that integrates each valve to form one structure may be used.
- An introduction channel 19 1 through which the 3-PBA solution flows from the antigen container 3 (an example of the “first channel” in the claims), and an introduction channel 19 2 through which the labeled 3-PBA solution flows from the labeled antigen container 5. (An example of the “second flow path” in the claims) merges at the junction C1. That is, the 3-PBA solution that flows when the pumps P1 and P2 operate and the valve V1 is open only in the horizontal direction of the drawing and the 3-PBA solution that flows when the valve V2 is open only in the horizontal direction of the drawing merge. When flow into the section C1, the introduction channel 19 8 on the downstream side of the merging portion C1 flows the mixture of 3-PBA solution and labeled 3-PBA solution.
- the introduction channel 19 8 that mixture flows, is connected to the upstream of the first mixing coil unit 27.
- the mixed solution of the 3-PBA solution and the labeled 3-PBA solution is sufficiently mixed by flowing through the first mixing coil unit 27.
- the 3-PBA solution and the labeled 3-PBA solution can be mixed in a short flow path, so that it is possible to provide a compact quantitative device 1.
- the introduction flow path 19 10 of the downstream side of the merging portion C3 is connected to the reaction cell 17.
- the introduction flow path 19 5 than H 2 O 2 for container 11 H 2 O 2 flows, an example of the "third channel" of the introduction flow path 19 6 (claimed flowing aniline-containing solution from an aniline solution container 13 ) Merge at the junction C2. That is, H 2 O 2 flowing when the pumps P5 and P6 operate and the valve V5 is open only in the horizontal direction of the drawing, and the aniline solution flowing when the valve V6 is open only in the horizontal direction of the drawing are connected to the junction C3. It flows when, in the introduction channel 19 9 downstream of the merging portion C2 is a mixture of H 2 O 2 and the aniline solution flows.
- Antibody fixing section is provided in the reaction cell 17.
- a plastic substrate for example, a PDMS substrate
- PDMS substrate for example, a plastic substrate
- the optical measurement channel 21 downstream of the reaction cell 17 is made of a light-transmitting material.
- an absorbance measuring section 23 for measuring the absorbance of polyaniline is provided.
- the absorbance measurement unit 23 includes a light source 31 (an example of a “light source unit”) that emits light for measuring absorbance, and a light projection that guides light emitted from the light source 31 to the optical measurement channel 21.
- Light guide path 33 (an example of the “first light guide path” in the claims), and a light receiving light guide path 35 (the “first light guide path” in the claims) that guides light that has passed through the polyaniline-containing solution in the optical measurement channel 21. 2) includes a light receiving sensor 37 (an example of a “light detecting unit”) that receives light guided by the light receiving light guiding path 35.
- noise light such as external light may enter the light-projecting light guide 33 and the light-receiving light guide 35.
- the light source 31, the light guide path 33 for light projection, the light guide path 35 for light reception, and the light reception sensor 37 are made of a light absorbing material (for example, a silicone resin containing a pigment such as carbon black).
- the light-shielding member 39 is made of
- the noise light that enters the light-projecting light guide 33 or the light-receiving light guide 35 the component that travels in the same direction as the optical axis of the light-projecting light guide 33 and the light-receiving light guide 35 is very small, and most of them are Light enters the light blocking member 39 from the interface between the light projecting light guide path 33 and the light blocking member 39 and the interface between the light receiving light guide path 35 and the light blocking member 39. At this time, the noise light incident on the light shielding member 39 is absorbed by the light absorbing member contained in the light shielding member 39. Therefore, it is possible to effectively reduce the influence of noise light (stray light) on the measurement result of the optical measurement.
- the light-projecting light guide 33 and the light-receiving light guide 35 are configured as cavities provided in the light-blocking member 39, and the light-projecting light guide 33 is transparent to light emitted from the light source 31. It can also be constituted by a resin (for example, a silicone resin). Similarly, the light receiving light guide path 35 can be made of a resin (for example, a silicone resin) transparent to light emitted from polyaniline.
- the transparent resin forming the light-projecting light guide path 33 and the light-receiving light guide path 35 and the resin containing the pigment forming the light shielding member 39 are made of the same material, the refractive indices of the two resins are the same. Therefore, reflection and scattering at the interface between the two resins are suppressed. That is, in this case, like the case where the light-projecting light guide path 33 and the light-receiving light guide path 35 are hollow, the stray light incident on the light shielding member 39 is absorbed by the pigment contained in the light shielding member 39.
- valves V1 to V7 valve control mechanism
- the pumps P1 to P7 the light source, and the light receiving sensor
- power supply means not shown
- control of opening / closing of the valves V1-V7 valve control mechanism
- control of the pumps P1-P7, the light source, and the light receiving sensor are performed by a control unit (not shown).
- the quantification of 3-PBA in the quantitative device 1 is performed as follows. First, the pump P3 is operated, the valve V3 is opened only in the horizontal direction of the drawing, and the antibody solution is introduced from the antibody container 7 into the reaction cell 17 through the junction C3. The antibody in the antibody solution introduced into the reaction cell 17 is adsorbed on the plastic substrate (S1).
- the operation of the pump P4 is stopped and the valve V4 is closed. Thereafter, the pumps P1 and P2 are operated to open the valves V1 and V2 only in the horizontal direction in the drawing, and the mixed solution of the 3-PBA solution from the antigen container 3 and the labeled 3-PBA solution from the labeled antigen container 5 is opened. Is sufficiently mixed by the first mixing coil unit 27 and passes through the junction C3, and then is introduced into the reaction cell 17. The introduced liquid mixture is adsorbed on the substrate and captured by the immobilized antibody (S3).
- the operations of the pumps P1 and P2 are stopped, and the valves V1 and V2 are closed. Then, by operating the pump P5 and P6, the valves V5 and V6 are opened state, a mixture of aniline-containing solution from H 2 O 2 and the aniline solution container 13 from the H 2 O 2 container 11, the After being sufficiently mixed by the two mixing coil sections 29 and passing through the junction C3, they are introduced into the reaction cell 17. Then, polyaniline is generated in the reaction cell 17 (S4), and the polyaniline-containing solution flows through the optical measurement channel 21 downstream of the reaction cell 17.
- the absorbance of the polyaniline is measured in an absorbance measurement section 23 provided around the optical measurement flow path 21 on the downstream side of the reaction cell 17 (S5), and the concentration of 3-PBA is calculated based on the absorbance. (S6).
- the introduction channel 19 and the reaction cell 17 are washed by appropriately flowing a running buffer between each step. For example, it washed as follows: for some outlet passageway 19 6, 19 9, 19 10 aniline solution flows.
- the pump P7 is operated and only the plug connected to the aniline container 13 of the valve V6 is closed and the other two plugs are opened, the running buffer is moved from the running buffer container 15 to the junction C2, The liquid is guided to pass through the second mixing coil 29 and the junction 3 and flows into the waste liquid container below the valve V7.
- the analysis by the flow analysis method is enabled, so that a competitive antigen-antibody reaction and polyaniline generation can be performed in the flow system, and the analysis can be performed quickly. -Convenience and reduction of sample (reagent) can be realized.
- the light guide path 33 for light projection and the light guide path 35 for light reception are configured to be surrounded by the light blocking member 39, so that noise light can be easily suppressed, and the noise as in the related art can be reduced. There is no need for a large-scale structure for light control. As a result, the quantitative device 1 of the present invention can be reduced in size and portability, and can realize relatively stable and quick measurement in an outdoor measurement environment.
- FIG. 3 shows (a) an absorption spectrum of a 1 mM aniline solution, and (b) an absorbance spectrum obtained by reacting 0.1 to 100 ppm of HRP, 1 mM of H 2 O 2 , and 10 mM of aniline in a batch system. Show. In (a), there is an absorption peak in the ultraviolet, whereas in (b) after the polymerization reaction, broad absorption is seen in the visible light region. In (b), the absorbance increases as the HRP concentration increases. As described above, since the absorption spectra of the monomer and the polymer are significantly different, the concentration of the polymer and the concentration of the target component can be accurately calculated from the absorbance after the polymerization reaction.
- FIG. 4 is a diagram showing a time change of absorbance at 410 nm when HRP, H 2 O 2 and aniline are reacted in a batch system.
- the absorbance reaches almost constant in several tens of seconds. That is, in the polymerization reaction of aniline, it can be said that stable data can be obtained in a relatively short time.
- target components to be quantified are not limited to endocrine disrupters contained in soil, but may be those present in environments such as rivers and oceans.
- the antibody solution was flowed from the antibody container to the reaction cell, and the antibody was adsorbed on the substrate in the reaction cell.
- the substrate on which the antibody had been adsorbed in advance may be installed in the reaction cell. .
- the number of the containers for the running buffer is one.
- a plurality of containers for the running buffer are provided. You may.
- the measurement wavelength may be any wavelength that can appropriately measure the absorbance of polyaniline, preferably 400 nm to 430 nm, and more preferably 405 nm to 410 nm.
- an example using the competitive ELISA method was described, but a direct teaching method, an indirect method, or a sandwich method may be used.
- a direct teaching method, an indirect method, or a sandwich method may be used.
- an antigen is added to cause a first antigen-antibody reaction, and a labeled antibody is further added thereto to cause a second antigen-antibody reaction.
- the competition method as shown in the Examples, the antigen-antibody reaction is performed only once.
- quantification can be performed in a small number of steps, so that the work load of the measurer can be reduced, and the time required for quantification can be reduced, and a quantification method suitable for on-site analysis can be provided. Will be possible.
- 1 ... quantification device 3 ... antigen container, container 5 ... labeled antigen, 7 ... antibodies container, 9 ... blocking agent container, for 11 ... H 2 O 2 Vessel, 13: Vessel for aniline, 15: Vessel for running buffer, 17: Reaction cell, 19: Introductory channel, P1-P7 ... Pump, V1-V7 ... Three-way valve , 21 ... Optical measurement channel, 23 ... Absorbance measurement unit, 25 ... Waste liquid container, 27 ... First mixed coil unit, 29 ... Second mixed coil unit, 31 ... Light source, 33: light guide path for projecting light, 35: light guide path for light reception, 37: light receiving sensor, 39: light shielding member
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
本発明は、内分泌攪乱物質等の定量方法及び定量装置に関するものである。 (4) The present invention relates to a method and an apparatus for quantifying an endocrine disrupter or the like.
内分泌攪乱物質(所謂、環境ホルモン)による環境汚染が注目されている。内分泌攪乱物質は、土壌、河川、海洋などの環境に排出された農薬等の化学物質が前記環境に生息する微生物により代謝毒性化したものである。近年、環境中における農薬等の化学物質や当該化学物質に由来する内分泌攪乱物質(以下、「内分泌攪乱物質等」とする。)の測定・分析に対する要請が高まってきた。 環境 Environmental pollution due to endocrine disrupters (so-called environmental hormones) has attracted attention. The endocrine disrupting substance is a substance in which a chemical substance such as a pesticide discharged into the environment such as soil, river, and ocean is metabolically toxic by microorganisms that live in the environment. In recent years, there has been an increasing demand for measurement and analysis of chemical substances such as pesticides in the environment and endocrine disrupting substances derived from the chemical substances (hereinafter referred to as “endocrine disrupting substances and the like”).
内分泌攪乱物質等の定量方法としては、従来より、ガスクロマトグラフ質量分析(例えば、高分解能ガスクロマトグラフ分析:HRGC/MS,高分解能質量分析HRGC/HRMS)法や、液体クロマトグラフ(例えば、高速液体クロマトグラフ:HPLC)法、ELISA等の光学測定が用いられてきた(特許文献1)。 Conventional methods for quantifying endocrine disruptors include gas chromatograph mass spectrometry (eg, high resolution gas chromatographic analysis: HRGC / MS, high resolution mass spectrometry HRGC / HRMS) and liquid chromatograph (eg, high performance liquid chromatograph). Graph: HPLC) method and optical measurement such as ELISA have been used (Patent Document 1).
しかしながら、従来の内分泌攪乱物質等の定量方法は、測定精度や感度は高いものの、比較的大型の装置を必要とするため、基本的には研究所等の分析拠点にて実施されることを前提としていて、内分泌攪乱物質等の採取現場において実施することは困難であった。 However, the conventional methods for quantifying endocrine disruptors, etc. require high-precision measurement and sensitivity, but require relatively large equipment. However, it was difficult to implement at the site where endocrine disruptors were collected.
本発明は係る事情によりなされたものであって、内分泌攪乱物質等のような環境試料検体を採取した現場で実施できる定量方法等を提供することを目的とする。 The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a quantification method and the like which can be carried out at a site where an environmental sample such as an endocrine disruptor is collected.
本発明の第1の観点は、抗原抗体反応を利用して試料溶液に含まれる対象成分を定量する定量方法であって、酵素で標識されている酵素標識抗原又は酵素標識抗体を、前記酵素標識抗原に対応する抗体又は前記酵素標識抗体に対応する抗原が入っている反応部に加え、抗原抗体反応をさせる抗原抗体反応工程と、前記酵素により重合反応が促進されるモノマーを前記反応部に加え、前記モノマーからポリマーを生成する重合反応をさせる重合反応工程と、前記重合反応工程で生成された前記ポリマーの吸光度を測定する吸光度測定工程と、前記吸光度測定工程で得られた吸光度から、前記対象成分を定量する定量工程とを含む。 A first aspect of the present invention is a quantification method for quantifying a target component contained in a sample solution using an antigen-antibody reaction, wherein the enzyme-labeled antigen or enzyme-labeled antibody labeled with an enzyme is labeled with the enzyme-labeled enzyme. In addition to the reaction section containing the antibody corresponding to the antigen or the antigen corresponding to the enzyme-labeled antibody, an antigen-antibody reaction step of causing an antigen-antibody reaction, and adding a monomer whose polymerization reaction is promoted by the enzyme to the reaction section A polymerization reaction step of performing a polymerization reaction to generate a polymer from the monomer, an absorbance measurement step of measuring the absorbance of the polymer generated in the polymerization reaction step, and from the absorbance obtained in the absorbance measurement step, the target A quantification step of quantifying the components.
本発明の第2の観点は、第1の観点の定量方法であって、前記モノマーがアニリンであり、前記ポリマーがポリアニリンである。 第 A second aspect of the present invention is the method for quantification according to the first aspect, wherein the monomer is aniline and the polymer is polyaniline.
本発明の第3の観点は、第1又は第2の観点の定量方法であって、前記抗原抗体反応工程において、前記抗体が入っている前記反応部に、前記酵素標識抗原とともに、酵素で標識していない前記試料溶液を加える。 A third aspect of the present invention is the quantification method according to the first or second aspect, wherein in the antigen-antibody reaction step, the reaction part containing the antibody is labeled with an enzyme together with the enzyme-labeled antigen. Add the unsampled sample solution.
本発明の第4の観点は、抗原抗体反応を利用して試料溶液に含まれる対象成分を定量する定量装置であって、前記抗原抗体反応の反応場とする反応部と、前記試料溶液を保持するための第1容器と、酵素で標識されていて、かつ、前記抗原抗体反応の抗原又は抗体である酵素標識物を含む酵素標識物溶液を保持するための第2容器と、前記酵素により促進される重合反応の基質溶液を保持するための第3容器と、前記第1容器内の前記試料溶液を前記反応部に導く第1流路と、前記第2容器内の前記酵素標識物溶液を前記反応部に導く第2流路と、前記第3容器内の前記基質溶液を前記反応部に導く第3流路と、前記反応部内の溶液を外部に導く第4流路と、前記重合反応により生成される重合体が吸収する波長を含む光を発する光源部と、光を検出する光検出部と、前記光源部が発する光を前記第4流路の一部である測定部に導光する第1導光路と、前記測定部からの光を前記光検出部に導光する第2導光路と、前記第1導光路及び前記第2導光路の周囲を包囲する、光を吸収する吸光部とを備える。 A fourth aspect of the present invention is a quantification apparatus for quantifying a target component contained in a sample solution by utilizing an antigen-antibody reaction, wherein the reaction section serves as a reaction field of the antigen-antibody reaction, and holds the sample solution. And a second container for holding an enzyme-labeled solution containing an enzyme-labeled product which is labeled with an enzyme and which is an antigen or an antibody in the antigen-antibody reaction, and is promoted by the enzyme. A third container for holding a substrate solution for the polymerization reaction to be performed, a first flow path for guiding the sample solution in the first container to the reaction section, and a solution of the enzyme-labeled substance in the second container. A second flow path leading to the reaction section, a third flow path leading the substrate solution in the third container to the reaction section, a fourth flow path leading the solution in the reaction section to the outside, A light source unit that emits light containing a wavelength that is absorbed by the polymer produced by A light detection unit that detects light, a first light guide path that guides light emitted by the light source unit to a measurement unit that is a part of the fourth flow path, and light from the measurement unit to the light detection unit. A second light guide path for guiding light; and a light absorbing portion that absorbs light and surrounds the first light guide path and the second light guide path.
本発明の第5の観点は、第4の観点の定量装置であって、前記吸光部が、光を吸収する顔料を含有する顔料含有シリコーン部材からなる。 A fifth aspect of the present invention is the quantitative device according to the fourth aspect, wherein the light-absorbing section is made of a pigment-containing silicone member containing a pigment that absorbs light.
本発明の第6の観点は、第4又は第5の観点の定量装置であって、前記第1導光路、前記第2導光路、及び、前記吸光部は、屈折率が同一のシリコーン樹脂を素材とする。 A sixth aspect of the present invention is the quantitative device according to the fourth or fifth aspect, wherein the first light guide, the second light guide, and the light absorbing unit are made of silicone resin having the same refractive index. Material.
本発明の第7の観点は、第4から第6のいずれかの観点の定量装置であって、前記第1流路と、前記第2流路とは、前記反応部よりも上流で合流している。 A seventh aspect of the present invention is the quantitative device according to any one of the fourth to sixth aspects, wherein the first flow path and the second flow path are joined upstream from the reaction unit. ing.
本発明の第8の観点は、第4から第7のいずれかの観点の定量装置であって、前記抗原抗体反応に用いる抗体溶液を保持するための第4容器と、前記第4容器内の前記抗体溶液を前記反応部に導く第4流路とを備え、前記酵素標識物は、酵素標識された抗原である酵素標識抗原である。 An eighth aspect of the present invention is the quantitative device according to any one of the fourth to seventh aspects, wherein a fourth container for holding an antibody solution used for the antigen-antibody reaction, A fourth flow path for guiding the antibody solution to the reaction section, wherein the enzyme-labeled product is an enzyme-labeled antigen that is an enzyme-labeled antigen.
本発明の各観点によれば、内分泌攪乱物質等の採取現場において吸光度を測定し、内分泌攪乱物質等を定量することが可能になる。 According to each aspect of the present invention, it becomes possible to measure the absorbance at the site of collecting endocrine disrupting substances and the like to quantify the endocrine disrupting substances and the like.
また、本発明の各観点によれば、酵素により触媒される反応が重合反応であるため、蛍光基質や発色基質を用いる従来のELISAに比べて、光や熱による影響を受けにくく、屋外での測定に適した定量方法等を提供することが可能になる。また、重合反応の反応時間は短いため、短時間で内分泌攪乱物質等を定量することが可能になる。 Further, according to each aspect of the present invention, the reaction catalyzed by the enzyme is a polymerization reaction, so that the reaction is less affected by light or heat as compared with a conventional ELISA using a fluorescent substrate or a chromogenic substrate, and it can be used outdoors. It is possible to provide a quantification method or the like suitable for measurement. In addition, since the reaction time of the polymerization reaction is short, it is possible to quantify endocrine disrupting substances and the like in a short time.
本発明の第2の観点によれば、反応時間が短いアニリンのラジカル重合反応を利用しているため、短時間で定量することが可能になる。また、アニリンは、従来のELISAで用いる蛍光基質に比べ、光や熱に対して安定であるため、本発明の定量方法は屋外測定に適している。さらに、アニリンは安価であるため、従来のELISAのような高価な蛍光試薬は不要である。 According to the second aspect of the present invention, the quantification can be performed in a short time because the aniline radical polymerization reaction having a short reaction time is used. In addition, aniline is more stable to light and heat than fluorescent substrates used in conventional ELISA, and thus the quantification method of the present invention is suitable for outdoor measurement. Furthermore, since aniline is inexpensive, expensive fluorescent reagents such as conventional ELISA are not required.
本発明の第3の観点によれば、ELISAの競合法を用いることにより、少ない工程で定量できるため、測定者の作業負担が軽減され、また、定量にかかる時間が短縮され、オンサイト分析に適した定量方法を提供することが可能になる。例えば、ELISAのサンドイッチ法では、抗体を基板に吸着させた後に、抗原を加えて1回目の抗原抗体反応をさせ、さらにそこに標識抗体を加えて2回目の抗原抗体反応をさせる。一方、競合法では、実施例に示す通り、抗原抗体反応は1回のみである。 According to the third aspect of the present invention, by using an ELISA competitive method, quantification can be performed in a small number of steps, so that the work load of the measurer is reduced, and the time required for quantification is reduced, and the on-site analysis is reduced. It becomes possible to provide a suitable quantification method. For example, in an ELISA sandwich method, after an antibody is adsorbed on a substrate, an antigen is added to cause a first antigen-antibody reaction, and a labeled antibody is further added thereto to cause a second antigen-antibody reaction. On the other hand, in the competition method, as shown in the Examples, the antigen-antibody reaction is performed only once.
本発明の第4の観点によれば、内分泌攪乱物質等の採取現場において吸光度を測定し、内分泌攪乱物質等を定量できる定量装置を提供することが可能になる。また、迷光は吸光部で吸収されるため、精度良く定量することが可能になる。 According to the fourth aspect of the present invention, it is possible to provide a quantification device that can measure the absorbance at a site where an endocrine disrupting substance or the like is collected to quantify the endocrine disrupting substance or the like. Further, since the stray light is absorbed by the light absorbing portion, it is possible to accurately determine the amount.
本発明の第5の観点によれば、吸光部に入射した迷光は、顔料により吸収される。そのため、第1導光路及び第2導光路を構成する透明樹脂に戻ることはほとんどない。さらに、吸光部から外部へ迷光が漏れることもない。そのため、迷光の複雑な多重反射がほとんど発生しない。 According to the fifth aspect of the present invention, the stray light incident on the light absorbing portion is absorbed by the pigment. Therefore, it hardly returns to the transparent resin forming the first light guide path and the second light guide path. Further, no stray light leaks from the light absorbing portion to the outside. Therefore, complicated multiple reflection of stray light hardly occurs.
本発明の第6の観点によれば、第1導光路及び第2導光路を構成する透明樹脂と、吸光部を構成する顔料含有樹脂との樹脂の材質を同じにすることにより、両樹脂が接触する界面において光の反射や散乱を抑制することが可能になる。 According to the sixth aspect of the present invention, the transparent resin forming the first light guide path and the second light guide path and the pigment-containing resin forming the light-absorbing portion are made of the same resin, so that both resins are formed. It becomes possible to suppress the reflection and scattering of light at the contacting interface.
本発明の第7の観点によれば、第1容器内の試料溶液と第2容器内の酵素標識物溶液を混合してから、反応部に導くことが可能になる。 According to the seventh aspect of the present invention, it is possible to mix the sample solution in the first container and the enzyme-labeled product solution in the second container, and then guide the mixture to the reaction section.
本発明の第8の観点によれば、抗体を反応部内の基板に吸着させた後に、定量対象である抗原と酵素標識抗原を競合的に抗体に反応させることが容易になる。 According to the eighth aspect of the present invention, the antigen to be quantified and the enzyme-labeled antigen can be made to react with the antibody competitively after the antibody is adsorbed on the substrate in the reaction section.
以下、図面を参照して、本発明の実施例について述べる。なお、本発明の実施の形態は、以下の実施例に限定されるものではない。 Hereinafter, embodiments of the present invention will be described with reference to the drawings. The embodiments of the present invention are not limited to the following examples.
図1に、本発明の内分泌攪乱物質等の定量方法のフロー図を示す。本実施例では、定量対象をジフェニルエーテル系除草剤の代謝物質の一種である3-フェノキシ安息香酸(3-phenoxybenzoic acid:3-PBA)とした。また、酵素には、西洋ワサビペルオキシダーゼ(Horse Radish Peroxidase:HRP)を用いた。なお、末端にCOOH基又はNH2基を有する化学物質であれば、HRPにより標識可能である。また、各溶液の溶媒には、リン酸緩衝液(Phosphate buffer)を用いた。 FIG. 1 shows a flow chart of the method for quantifying an endocrine disrupter or the like of the present invention. In this example, the object of quantification was 3-phenoxybenzoic acid (3-PBA), which is a kind of metabolite of a diphenyl ether herbicide. Horseradish peroxidase (HRP) was used as the enzyme. Note that any chemical substance having a COOH group or an NH 2 group at the terminal can be labeled with HRP. In addition, a phosphate buffer (Phosphate buffer) was used as a solvent for each solution.
まず、3-PBAと特異的に結合する抗3-PBA抗体を反応セル(請求項記載の「反応部」の一例)に注入し、反応セル内の基板に吸着させる(S1)。次に、ウシ血清アルブミン(BSA)を反応セルに注入する(S2)。BSAは、次のステップで注入する標識抗原が基板に非特異的に吸着することを抑制するためのブロッキング剤である。続いて、定量対象の3-PBA溶液(請求項記載の「試料溶液」の一例)と、標識3-PBA溶液(請求項記載の「酵素標識物」及び「酵素標識抗原」の一例)との混合液を反応セルに注入する(S3、請求項記載の「抗原抗体反応工程」の一例)。ここで、標識3-PBA溶液は、抗原である3-PBAをHRPで予め標識した標識3-PBAを含む溶液であって、標識3-PBAの濃度は既知である。3-PBA溶液と標識3-PBA溶液の混合液が注入されると、標識されていない3-PBAと標識3-PBAが競合的に基板上の抗体により補足され、抗原抗体反応が起こる。そして、洗浄後、アニリンと過酸化水素(H2O2)を反応セルに注入する(S4、請求項記載の「重合反応工程」の一例)。すると、基板上の抗体に補足された標識3-PBAのHRPにより、下記の化学反応が触媒され、アニリンからポリアニリンが生成される重合反応が起こる。重合反応の後、ポリアニリンの吸光度を測定する(S5、請求項記載の「吸光度測定工程」の一例)。最後に、得られた吸光度に基づいて、3-PBAの濃度を算出する(S6、請求項記載の「定量工程」の一例)。 First, an anti-3-PBA antibody that specifically binds to 3-PBA is injected into a reaction cell (an example of a “reaction section” in the claims) and adsorbed on a substrate in the reaction cell (S1). Next, bovine serum albumin (BSA) is injected into the reaction cell (S2). BSA is a blocking agent for suppressing nonspecific adsorption of the labeled antigen to be injected in the next step to the substrate. Subsequently, a 3-PBA solution to be quantified (an example of a “sample solution” in the claims) and a labeled 3-PBA solution (an example of an “enzyme-labeled substance” and an “enzyme-labeled antigen” in the claims) The mixture is injected into the reaction cell (S3, an example of the “antigen-antibody reaction step” in the claims). Here, the labeled 3-PBA solution is a solution containing labeled 3-PBA in which 3-PBA as an antigen is labeled in advance with HRP, and the concentration of labeled 3-PBA is known. When a mixture of the 3-PBA solution and the labeled 3-PBA solution is injected, unlabeled 3-PBA and labeled 3-PBA are competitively captured by the antibody on the substrate, and an antigen-antibody reaction occurs. After the washing, aniline and hydrogen peroxide (H 2 O 2 ) are injected into the reaction cell (S4, an example of the “polymerization reaction step” in the claims). Then, the following chemical reaction is catalyzed by HRP of the labeled 3-PBA captured by the antibody on the substrate, and a polymerization reaction in which polyaniline is generated from aniline occurs. After the polymerization reaction, the absorbance of the polyaniline is measured (S5, an example of the "absorbance measurement step" in claims). Finally, the concentration of 3-PBA is calculated based on the obtained absorbance (S6, an example of the "quantitative step" described in claims).
このように、本定量方法は、アニリンのラジカル重合反応を利用しているため、定量にかかる時間を従来のELISAに比べて大幅に短縮できる。従来のELISAの酵素反応にかかる時間は数分であるのに対し、本定量方法の重合反応にかかる時間は数秒である。また、アニリンは、従来のELISAで用いていた蛍光基質や発色基質に比べて、光や熱に対してはるかに安定であるため、オンサイト分析に適している。さらに、従来のELISAで用いていた基質に比べ、アニリンは安価である。つまり、本定量方法によれば、迅速、安全かつ安価に、内分泌攪乱物質等のオンサイト分析を行うことが可能になる。 As described above, since the present quantification method utilizes the radical polymerization reaction of aniline, the time required for quantification can be significantly reduced as compared with the conventional ELISA. The time required for the enzyme reaction of the conventional ELISA is several minutes, whereas the time required for the polymerization reaction of the present quantitative method is several seconds. Aniline is suitable for on-site analysis because it is far more stable to light and heat than fluorescent substrates and chromogenic substrates used in conventional ELISA. Furthermore, aniline is less expensive than the substrate used in the conventional ELISA. That is, according to the present quantification method, on-site analysis of endocrine disrupting substances and the like can be performed quickly, safely and inexpensively.
図2に、本発明の定量方法を実施するための定量装置1の構成例を示す。定量装置1は、流れ分析法(例えば、Flow Injection Analysis)による分析を可能としたものである。
FIG. 2 shows a configuration example of a
定量装置1は、定量対象である3-PBA溶液を保持するための抗原用容器3(請求項記載の「第1容器」の一例)と、標識3-PBA溶液を保持するための標識抗原用容器5(請求項記載の「第2容器」の一例)と、抗体溶液を保持するための抗体用容器7(請求項記載の「第4容器」の一例)と、BSAなどのブロッキング剤を保持するためのブロッキング剤用容器9と、過酸化水素水(H2O2)を保持するためのH2O2用容器11と、アニリン含有溶液を保持するためのアニリン用容器13(請求項記載の「第3容器」の一例)と、ランニングバッファを保持するためのランニングバッファ用容器15と、抗原抗体反応の反応場となる反応セル17(請求項記載の「反応部」の一例)と、各容器から反応セル17に溶液を導く導入流路19と、導入流路19中の溶液を流すためのポンプP1-P7と、導入流路19に設けた開閉制御可能な三方バルブV1-V7と、反応セル17から外部に溶液を導く光学測定用流路21(請求項記載の「第4流路」の一例)と、ポリアニリンの吸光度を測定する吸光度測定部23とを有する。なお上記した三方バルブの開閉制御は、流体の流れ方向の切り替え制御、流体の流れのOn・Off制御を含むものとする。
The
各容器(抗原用容器3、標識抗原用容器5、抗体用容器7、ブロッキング剤用容器9、H2O2用容器11、アニリン用容器13、ランニングバッファ用容器15)は、導入流路19(191、192、193、194、195、196、197)を通じてポンプP1-P7に接続され、ポンプP1-P7の駆動により各容器内の溶液が導入流路19内を流れ、反応セル17に入る。ポンプP1-P6の下流側には、開閉制御可能な三方バルブV1-V6が設けられている。後述する合流点C3と反応セル17の間の導入流路1910には、バルブV7が設けられ、もう一方が廃液入れ25に接続している。なお、図2においては、理解を容易にするため、各バルブ個別に示されているが、各バルブを集約して1つの構造体を成すバルブ制御機構であってもよい。
Each of the containers (the
抗原用容器3より3-PBA溶液が流れる導入流路191(請求項記載の「第1流路」の一例)と、標識抗原用容器5より標識3-PBA溶液が流れる導入流路192(請求項記載の「第2流路」の一例)とは、合流部C1で合流する。すなわち、ポンプP1及びP2が動作し、バルブV1が図面横方向のみ開状態のときに流れる3-PBA溶液と、バルブV2が図面横方向のみ開状態のときに流れる標識3-PBA溶液とが合流部C1に流れ込むと、当該合流部C1の下流側の導入流路198には、3-PBA溶液と標識3-PBA溶液の混合液が流れる。
An
この混合液が流れる導入流路198は、第1混合コイル部27の上流と接続される。3-PBA溶液と標識3-PBA溶液の混合液は、第1混合コイル部27を流れることにより十分に混合される。第1混合コイル部27を設けることにより、短い流路で3-PBA溶液と標識3-PBA溶液を混合できるため、コンパクトな定量装置1を提供することが可能になる。
The
第1混合コイル部27の下流側の導入流路198は、合流点C3において、ポンプP3が動作し、バルブV3が図面横方向のみ開状態のとき抗体用容器7より抗体溶液が流れる導入流路193と、ポンプP4が動作し、バルブV4が図面横方向のみ開状態のときブロッキング剤用容器9よりBSAが流れる導入流路194と、後で説明するように、H2O2及びアニリン溶液の混合液が流れる導入流路199と合流する。そして、合流部C3の下流側の導入流路1910は、反応セル17に連結される。
H2O2用容器11よりH2O2が流れる導入流路195と、アニリン溶液用容器13よりアニリン含有溶液が流れる導入流路196(請求項記載の「第3流路」の一例)は、合流部C2で合流する。すなわち、ポンプP5及びP6が動作し、バルブV5が図面横方向のみ開状態のときに流れるH2O2と、バルブV6が図面横方向のみ開状態のときに流れるアニリン溶液とが合流部C3に流れ込むと、当該合流部C2の下流側の導入流路199には、H2O2及びアニリン溶液の混合液が流れる。
The
合流部C2の下流側の導入流路199には、第2混合コイル部29が設けられ、第2混合コイル部29の下流側は、合流点C3に合流する。すなわち、合流部C2を通過したH2O2及びアニリン溶液の混合液は、第2混合コイル部29を流れることにより十分に混合される。
The
反応セル17内には、抗体定着部が設けられている。抗体定着部としては、例えば、プラスチック基板(例えば、PDMS基板)が用いられる。
抗体 Antibody fixing section is provided in the
反応セル17の下流側の光学測定用流路21は、光透過性材料からなる。この光学測定用流路21の周囲には、ポリアニリンの吸光度を測定するための吸光度測定部23が設けられる。吸光度測定部23は、吸光度測定用の光を放出する光源31(請求項記載の「光源部」の一例)と、光源31から放出される光を光学測定用流路21に導光する投光用導光路33(請求項記載の「第1導光路」の一例)、光学測定用流路21内のポリアニリン含有溶液を通過した光を導光する受光用導光路35(請求項記載の「第2導光路」の一例)、受光用導光路35により導光される光を受光する受光センサ37(請求項記載の「光検出部」の一例)を含む。
光学 The
ここで、投光用導光路33及び受光用導光路35には、外光等のノイズ光(迷光)が侵入しうる。この外光の影響を抑制するために、光源31、投光用導光路33、受光用導光路35及び受光センサ37は、光吸収性材料(例えば、カーボンブラック等の顔料を含有するシリコーン樹脂)からなる遮光部材39(請求項記載の「吸光部」の一例)により包囲される。
Here, noise light (stray light) such as external light may enter the light-projecting
投光用導光路33又は受光用導光路35に侵入するノイズ光のうち、投光用導光路33、受光用導光路35の光軸と同方向に進む成分は非常に少なく、大部分は、投光用導光路33と遮光部材39との界面、受光用導光路35と遮光部材39との界面から遮光部材39へ入射する。このとき、遮光部材39へ入射したノイズ光は、遮光部材39が含有する光吸収部材により吸収される。したがって、光学測定の測定結果に対するノイズ光(迷光)の影響を効果的に低減することが可能である。
Of the noise light that enters the light-projecting
投光用導光路33及び受光用導光路35は、遮光部材39に設けられた空洞部として構成されるが、上記投光用導光路33は、光源31から放出される光に対して透明な樹脂(例えば、シリコーン樹脂)により構成することもできる。同様に、受光用導光路35は、ポリアニリンから放出される光に対して透明な樹脂(例えば、シリコーン樹脂)により構成することもできる。
The light-projecting
ここで、投光用導光路33、受光用導光路35を構成する透明な樹脂と、遮光部材39を構成する顔料を含有する樹脂との材質を同じにすると、前記両樹脂の屈折率が同じであるので、当該両樹脂の界面での反射および散乱が抑制される。すなわち、この場合、投光用導光路33、受光用導光路35が空洞である場合と同様に、遮光部材39へ入射した迷光は遮光部材39が含有する上記顔料により吸収されるが、さらに、投光用導光路33、受光用導光路35と遮光部材39との界面での反射および散乱が抑制されるので、遮光部材39へ入射した迷光は投光用導光路33、受光用導光路35にはほとんど戻らない。よって、迷光の複雑な多重反射がほとんど発生しない。
Here, if the transparent resin forming the light-projecting
なお、バルブV1-V7(バルブ制御機構)、ポンプP1-P7、光源、受光センサへの給電は図示を省略した給電手段により行われる。同様に、バルブV1-V7(バルブ制御機構)の開閉制御、ポンプP1-P7、光源、受光センサの制御は、図示を省略した制御部により行われる。 The power supply to the valves V1 to V7 (valve control mechanism), the pumps P1 to P7, the light source, and the light receiving sensor is performed by power supply means (not shown). Similarly, control of opening / closing of the valves V1-V7 (valve control mechanism) and control of the pumps P1-P7, the light source, and the light receiving sensor are performed by a control unit (not shown).
本定量装置1における3-PBAの定量は以下のように行われる。まず、ポンプP3を動作させ、バルブV3を図面横方向のみ開状態として、抗体用容器7より抗体溶液が、合流点C3を通過して、反応セル17内に導入される。反応セル17内に導入された抗体溶液中の抗体は、プラスチック基板上に吸着される(S1)。
定量 The quantification of 3-PBA in the
上記基板上に抗体が吸着された後、ポンプP3の動作を停止し、バルブV3を閉状態とする。その後、ポンプP4を動作させ、バルブV4を図面横方向のみ開状態として、ブロッキング剤用容器9よりBSAが、合流点C3を通過して、反応セル17内に導入される(S2)。反応セル17内にBSAを導入するのは、後に反応セル17内に導入される標識3-PBAが、抗体に認識されずに基板上に非特異的に吸着するのを抑制するためである。
(4) After the antibody is adsorbed on the substrate, the operation of the pump P3 is stopped, and the valve V3 is closed. Thereafter, the pump P4 is operated to open the valve V4 only in the lateral direction in the drawing, and BSA is introduced into the
反応セル17内にBSAを導入後、ポンプP4の動作を停止し、バルブV4を閉状態とする。その後、ポンプP1及びP2を動作させ、バルブV1及びV2を図面横方向のみ開状態として、抗原用容器3からの3-PBA溶液と標識抗原用容器5からの標識3-PBA溶液との混合液が、第1混合コイル部27により十分混合されて合流部C3を通過後、反応セル17内に導入される。導入された上記混合液は、基板上に吸着されて固定化された抗体に捕捉される(S3)。
BS After introducing BSA into the
抗原抗体反応を起こした後、ポンプP1及びP2の動作を停止し、バルブV1及びV2を閉状態とする。次に、ポンプP5及びP6を動作させ、バルブV5及びV6を開状態として、H2O2容器11からのH2O2とアニリン溶液用容器13からのアニリン含有溶液との混合液が、第2混合コイル部29により十分混合されて合流部C3を通過後、反応セル17内に導入される。すると、反応セル17にて、ポリアニリンが生成され(S4)、反応セル17の下流側の光学測定用流路21には、ポリアニリン含有溶液が流れる。
After the antigen-antibody reaction occurs, the operations of the pumps P1 and P2 are stopped, and the valves V1 and V2 are closed. Then, by operating the pump P5 and P6, the valves V5 and V6 are opened state, a mixture of aniline-containing solution from H 2 O 2 and the
そして、反応セル17の下流側の光学測定用流路21の周囲に設けられた吸光度測定部23において、ポリアニリンの吸光度が測定され(S5)、その吸光度に基づいて3-PBAの濃度が算出される(S6)。なお、導入流路19及び反応セル17は、各工程の間に適宜ランニングバッファを流すことにより洗浄される。例えば、アニリン溶液が流れる導出流路196、199、1910の一部については次のように洗浄する。ポンプP7を動作させ、バルブV6のアニリン用容器13に接続している栓のみを閉状態とし、他の二つの栓を開状態とすると、ランニングバッファ用容器15よりランニングバッファが、合流点C2、第2混合コイル29及び合流点3を通過するよう導かれ、バルブV7の下方の被廃液入れに流れる。
Then, the absorbance of the polyaniline is measured in an
以上のように、本発明の定量装置1によれば、流れ分析法による分析を可能としたので、流れ系において、競合的な抗原抗体反応やポリアニリン生成を行うことが可能となり、分析において迅速性・簡便性・省試料(試薬)化を実現できる。また、吸光度測定部23において、投光用導光路33及び受光用導光路35を遮光部材39で包囲した構造としたので、ノイズ光の抑制を容易に実施することができ、従来のようにノイズ光対策のための大がかりな構造を必要としない。結果的に本発明の定量装置1は、小型化・携帯化が可能となり、かつ、屋外の測定環境に比較的安定で、迅速な測定を実現することができる。
As described above, according to the
図3に、(a)1mMのアニリン溶液の吸収スペクトルと、(b)バッチ系で0.1から100ppmのHRPと、1mMのH2O2と、10mMのアニリンを反応させ場合の吸光度スペクトルを示す。(a)では紫外部に吸収ピークがあるのに対し、重合反応後の(b)では可視光領域にブロードな吸収がみられる。また、(b)では、HRP濃度の増加に伴い、吸光度が大きくなっている。このように、モノマーとポリマーの吸収スペクトルが大きく異なるため、重合反応後の吸光度からポリマーの濃度及び目的成分の濃度を精度よく算出することができる。 FIG. 3 shows (a) an absorption spectrum of a 1 mM aniline solution, and (b) an absorbance spectrum obtained by reacting 0.1 to 100 ppm of HRP, 1 mM of H 2 O 2 , and 10 mM of aniline in a batch system. Show. In (a), there is an absorption peak in the ultraviolet, whereas in (b) after the polymerization reaction, broad absorption is seen in the visible light region. In (b), the absorbance increases as the HRP concentration increases. As described above, since the absorption spectra of the monomer and the polymer are significantly different, the concentration of the polymer and the concentration of the target component can be accurately calculated from the absorbance after the polymerization reaction.
図4は、バッチ系でHRPとH2O2とアニリンを反応させた場合の410nm吸光度の時間変化を示す図である。吸光度は数十秒でほぼ一定に達している。つまり、アニリンの重合反応では、比較的短時間で安定したデータを得られるといえる。 FIG. 4 is a diagram showing a time change of absorbance at 410 nm when HRP, H 2 O 2 and aniline are reacted in a batch system. The absorbance reaches almost constant in several tens of seconds. That is, in the polymerization reaction of aniline, it can be said that stable data can be obtained in a relatively short time.
なお、定量する対象成分は、土壌に含まれる内分泌攪乱物質に限るものではなく、河川、海洋などの環境に存在するものであってもよい。 Note that the target components to be quantified are not limited to endocrine disrupters contained in soil, but may be those present in environments such as rivers and oceans.
また、上記実施例においては、抗体用容器から反応セルに抗体溶液を流し、反応セル内の基板に抗体を吸着させたが、予め抗体を吸着させた基板を反応セル内に設置してもよい。 Further, in the above embodiment, the antibody solution was flowed from the antibody container to the reaction cell, and the antibody was adsorbed on the substrate in the reaction cell. However, the substrate on which the antibody had been adsorbed in advance may be installed in the reaction cell. .
また、実施例の定量装置ではランニングバッファ用容器は1つであるが、反応セル内のpHを酵素反応と抗原抗体反応のそれぞれの最適pHに調整するために、複数のランニングバッファ用容器を備えてもよい。 In the quantitative apparatus of the embodiment, the number of the containers for the running buffer is one. However, in order to adjust the pH in the reaction cell to the optimum pH for each of the enzyme reaction and the antigen-antibody reaction, a plurality of containers for the running buffer are provided. You may.
なお、測定波長は、ポリアニリンの吸光度を適切に測定できる波長であればよく、400nm-430nmであれば好ましく、405nm-410nmであればさらに好ましい。 The measurement wavelength may be any wavelength that can appropriately measure the absorbance of polyaniline, preferably 400 nm to 430 nm, and more preferably 405 nm to 410 nm.
また、上記実施例では、ELISAの競合法を用いた例を示したが、直説法、間接法、又は、サンドイッチ法を用いてもよい。例えば、ELISAのサンドイッチ法では、抗体を基板に吸着させた後に、抗原を加えて1回目の抗原抗体反応をさせ、さらにそこに標識抗体を加えて2回目の抗原抗体反応をさせる。一方、競合法では、実施例に示す通り、抗原抗体反応は1回のみである。そのため、ELISAの競合法を用いることにより、少ない工程で定量できるため、測定者の作業負担が軽減され、また、定量にかかる時間が短縮され、オンサイト分析に適した定量方法を提供することが可能になる。 Also, in the above-described embodiment, an example using the competitive ELISA method was described, but a direct teaching method, an indirect method, or a sandwich method may be used. For example, in an ELISA sandwich method, after an antibody is adsorbed on a substrate, an antigen is added to cause a first antigen-antibody reaction, and a labeled antibody is further added thereto to cause a second antigen-antibody reaction. On the other hand, in the competition method, as shown in the Examples, the antigen-antibody reaction is performed only once. Therefore, by using an ELISA competitive method, quantification can be performed in a small number of steps, so that the work load of the measurer can be reduced, and the time required for quantification can be reduced, and a quantification method suitable for on-site analysis can be provided. Will be possible.
1・・・定量装置、3・・・抗原用容器、5・・・標識抗原用容器、7・・・抗体用容器、9・・・ブロッキング剤用容器、11・・・H2O2用容器、13・・・アニリン用容器、15・・・ランニングバッファ用容器、17・・・反応セル、19・・・導入流路、P1-P7・・・ポンプ、V1-V7・・・三方バルブ、21・・・光学測定用流路、23・・・吸光度測定部、25・・・廃液入れ、27・・・第1混合コイル部、29・・・第2混合コイル部、31・・・光源、33・・・投光用導光路、35・・・受光用導光路、37・・・受光センサ、39・・・遮光部材
1 ... quantification device, 3 ... antigen container,
Claims (8)
酵素で標識されている酵素標識抗原又は酵素標識抗体を、前記酵素標識抗原に対応する抗体又は前記酵素標識抗体に対応する抗原が入っている反応部に加え、抗原抗体反応をさせる抗原抗体反応工程と、
前記酵素により重合反応が促進されるモノマーを前記反応部に加え、前記モノマーからポリマーを生成する重合反応をさせる重合反応工程と、
前記重合反応工程で生成された前記ポリマーの吸光度を測定する吸光度測定工程と、
前記吸光度測定工程で得られた吸光度から、前記対象成分を定量する定量工程とを含む、定量方法。 A quantitative method for quantifying a target component contained in a sample solution using an antigen-antibody reaction,
An antigen-antibody reaction step of adding an enzyme-labeled antigen or an enzyme-labeled antibody labeled with an enzyme to a reaction section containing an antibody corresponding to the enzyme-labeled antigen or an antigen corresponding to the enzyme-labeled antibody, and causing an antigen-antibody reaction When,
A polymerization reaction step of adding a monomer whose polymerization reaction is promoted by the enzyme to the reaction section and causing a polymerization reaction to generate a polymer from the monomer,
Absorbance measurement step of measuring the absorbance of the polymer generated in the polymerization reaction step,
A quantification step of quantifying the target component from the absorbance obtained in the absorbance measurement step.
前記抗原抗体反応の反応場とする反応部と、
前記試料溶液を保持するための第1容器と、
酵素で標識されていて、かつ、前記抗原抗体反応の抗原又は抗体である酵素標識物を含む酵素標識物溶液を保持するための第2容器と、
前記酵素により促進される重合反応の基質溶液を保持するための第3容器と、
前記第1容器内の前記試料溶液を前記反応部に導く第1流路と、
前記第2容器内の前記酵素標識物溶液を前記反応部に導く第2流路と、
前記第3容器内の前記基質溶液を前記反応部に導く第3流路と、
前記反応部内の溶液を外部に導く第4流路と、
前記重合反応により生成される重合体が吸収する波長を含む光を発する光源部と、
光を検出する光検出部と、
前記光源部が発する光を前記第4流路の一部である測定部に導光する第1導光路と、
前記測定部からの光を前記光検出部に導光する第2導光路と、
前記第1導光路及び前記第2導光路の周囲を包囲する、光を吸収する吸光部とを備える、定量装置。 A quantitative device for quantifying a target component contained in a sample solution using an antigen-antibody reaction,
A reaction unit that serves as a reaction field for the antigen-antibody reaction,
A first container for holding the sample solution;
A second container for holding an enzyme-labeled product solution containing an enzyme-labeled product that is labeled with an enzyme, and that is an antigen or an antibody in the antigen-antibody reaction,
A third container for holding a substrate solution for the polymerization reaction promoted by the enzyme;
A first channel for guiding the sample solution in the first container to the reaction section,
A second flow path for guiding the enzyme-labeled product solution in the second container to the reaction section,
A third channel for guiding the substrate solution in the third container to the reaction section,
A fourth channel for guiding the solution in the reaction section to the outside,
A light source unit that emits light including a wavelength that is absorbed by the polymer generated by the polymerization reaction,
A light detection unit for detecting light,
A first light guide path that guides light emitted by the light source unit to a measurement unit that is a part of the fourth flow path;
A second light guide path for guiding light from the measurement unit to the light detection unit,
A light-absorbing unit that surrounds the first light guide and the second light guide and that absorbs light.
前記第4容器内の前記抗体溶液を前記反応部に導く第4流路とを備え、
前記酵素標識物は、酵素標識された抗原である酵素標識抗原である、請求項4から7のいずれかに記載の定量装置。 A fourth container for holding an antibody solution used for the antigen-antibody reaction,
A fourth flow path that guides the antibody solution in the fourth container to the reaction section,
The quantification device according to claim 4, wherein the enzyme-labeled product is an enzyme-labeled antigen that is an enzyme-labeled antigen.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-169583 | 2018-09-11 | ||
| JP2018169583A JP2020041909A (en) | 2018-09-11 | 2018-09-11 | Method and device for quantifying endocrine disruptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2020054300A1 true WO2020054300A1 (en) | 2020-03-19 |
Family
ID=69777535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2019/031837 Ceased WO2020054300A1 (en) | 2018-09-11 | 2019-08-13 | Method and apparatus for determining quantity of endocrine disruptor and like |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2020041909A (en) |
| WO (1) | WO2020054300A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021181987A1 (en) * | 2020-03-11 | 2021-09-16 | 国立大学法人九州大学 | Method for determining quantity of endocrine disruptor and like |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002522748A (en) * | 1998-05-04 | 2002-07-23 | テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド | Detection of targets in samples |
| JP2004500456A (en) * | 2000-01-04 | 2004-01-08 | ドナルドソン カンパニー,インコーポレイティド | Method for producing polyaniline |
| JP2004069395A (en) * | 2002-08-02 | 2004-03-04 | Nec Corp | Microchip, method for manufacturing the same, and constituent detection method |
| JP2010111751A (en) * | 2008-11-05 | 2010-05-20 | Asahi Kasei Fibers Corp | Soluble aniline-based chromism polymer and method for producing the same |
| WO2015060269A1 (en) * | 2013-10-21 | 2015-04-30 | 国立大学法人大阪大学 | Method for determining concentration of substance to be detected, and detector |
-
2018
- 2018-09-11 JP JP2018169583A patent/JP2020041909A/en active Pending
-
2019
- 2019-08-13 WO PCT/JP2019/031837 patent/WO2020054300A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002522748A (en) * | 1998-05-04 | 2002-07-23 | テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド | Detection of targets in samples |
| JP2004500456A (en) * | 2000-01-04 | 2004-01-08 | ドナルドソン カンパニー,インコーポレイティド | Method for producing polyaniline |
| JP2004069395A (en) * | 2002-08-02 | 2004-03-04 | Nec Corp | Microchip, method for manufacturing the same, and constituent detection method |
| JP2010111751A (en) * | 2008-11-05 | 2010-05-20 | Asahi Kasei Fibers Corp | Soluble aniline-based chromism polymer and method for producing the same |
| WO2015060269A1 (en) * | 2013-10-21 | 2015-04-30 | 国立大学法人大阪大学 | Method for determining concentration of substance to be detected, and detector |
Non-Patent Citations (1)
| Title |
|---|
| SHIMIZU,SHINICHI ET AL: "Development of flow absorption ELISA method based on polyaniline formation for the purpose of quantitative analysis of metabolites of diphenyl ether herbicides", LECTURE ABSTRACTS OF THE 67TH ANNUAL MEETING OF THE JAPAN SOCIETY FOR ANALYTICAL CHEMISTRY, THE JAPAN SOCIETY FOR ANALYTICAL CHEMISTRY, no. J1005, 29 August 2018 (2018-08-29), pages 193 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021181987A1 (en) * | 2020-03-11 | 2021-09-16 | 国立大学法人九州大学 | Method for determining quantity of endocrine disruptor and like |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020041909A (en) | 2020-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tschmelak et al. | Automated Water Analyser Computer Supported System (AWACSS) Part I: Project objectives, basic technology, immunoassay development, software design and networking | |
| Soares et al. | A point-of-use microfluidic device with integrated photodetector array for immunoassay multiplexing: Detection of a panel of mycotoxins in multiple samples | |
| Mastichiadis et al. | Simultaneous determination of pesticides using a four-band disposable optical capillary immunosensor | |
| Van Emon et al. | A status report on field-portable immunoassay | |
| US20120170044A1 (en) | Polymer Analysis Chip | |
| Mallat et al. | River analyzer for chlorotriazines with a direct optical immunosensor | |
| Gao et al. | Optofluidic immunosensor based on resonant wavelength shift of a hollow core fiber for ultratrace detection of carcinogenic benzo [a] pyrene | |
| Ecke et al. | A rapid magnetic bead-based immunoassay for sensitive determination of diclofenac | |
| JP2007506978A (en) | Device, system and method for detecting a target in a fluid sample | |
| US7262857B2 (en) | Device for measuring immunochromatography test piece | |
| US9366619B2 (en) | Optical device for performing an assay | |
| WO2020054300A1 (en) | Method and apparatus for determining quantity of endocrine disruptor and like | |
| Kagawa et al. | Development of small-sized fluorescence detector for pipette tip-based biosensor for on-site diagnosis | |
| Walczak et al. | The application of evanescent wave sensing to a high-sensitivity fluoroimmunoassay | |
| CN1323296C (en) | Silane-crosslinked chitosan membrane-based flow injection chemiluminescence immunoassay cell and preparation method | |
| EP2404158A1 (en) | A device for assay of a liquid sample | |
| Wenger et al. | Au-labeled antibodies to enhance the sensitivity of a refractometric immunoassay: detection of cocaine | |
| Song et al. | A new green analytical procedure for monitoring sub-nanogram amounts of chlorpyrifos on fruits using flow injection chemiluminescence with immobilized reagents | |
| Wu et al. | Development of a smartphone-integrated handheld automated biochemical analyzer for point-of-care testing of urinary albumin | |
| Aoyagi et al. | Reagentless and regenerable immunosensor for monitoring of immunoglobulin G based on non-separation immunoassay | |
| Kim et al. | Sensitive “capillary elisa” via vapor-phase surface modification | |
| JP2021143835A (en) | Method for determining quantity of endocrine disrupting chemical | |
| Wang et al. | Simple microfluidic device for spectroelectrochemistry | |
| WO2021181987A1 (en) | Method for determining quantity of endocrine disruptor and like | |
| Rodriguez-Mozaz et al. | Achievements of the RIANA and AWACSS EU projects: immunosensors for the determination of pesticides, endocrine disrupting chemicals and pharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19860469 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19860469 Country of ref document: EP Kind code of ref document: A1 |